W. Edward Fiets

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 600 citations · Full text

A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients

Judith Honing, Justin K. Smit, Christina T. Muijs et al. · Annals of Oncology · 2014 · 118 citations · Full text

Esophageal Cancer Patients, Esophageal Cancer, Definitive Chemoradiation +5

Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients

W. Edward Fiets, R.P. van Helvoirt, J.W.R. Nortier et al. · European Journal of Cancer · 2003 · 85 citations

Breast Oncology, Radiation Therapy, Breast Cancer Patients +6

Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial

Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven et al. · The Lancet Oncology · 2025 · 61 citations · Full text

Surgical Oncology, Neoadjuvant Chemoradiotherapy, Esophageal Cancer +12

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

Wim van Putten, Michael Duffy, Nadia Harbeck et al. · Thrombosis and Haemostasis · 2003 · 56 citations

Nodal Status, Urology, Prognostic Impact +12